Testing effectiveness (Phase 2)Study completedNCT00965523What this trial is testingStudy of E7389 for Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Eisai Co., Ltd. 81
Testing effectiveness (Phase 2)Ended earlyNCT00101062What this trial is testingLetrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Looking for participantsNCT05300269What this trial is testingSHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal CancerWho this might be right forLocally Advanced Rectal Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 73
Large-scale testing (Phase 3)Ended earlyNCT04675983What this trial is testingSintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Who this might be right forGastric Adenocarcinoma Innovent Biologics (Suzhou) Co. Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT00077688What this trial is testingTOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumWho this might be right forBladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms+1 more Achieve Life Sciences 44
Large-scale testing (Phase 3)Not Yet RecruitingNCT06858410What this trial is testingLorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung AdenocarcinomaWho this might be right forNeoadjuvant Non-Small Cell Lung Cancer Guangdong Association of Clinical Trials 36
Early research (Phase 1)Study completedNCT01295827What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)Who this might be right forCancer, Solid Tumor Merck Sharp & Dohme LLC 1,260
Testing effectiveness (Phase 2)Ended earlyNCT02067741What this trial is testingCR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerWho this might be right forMetastatic Breast AdenocarcinomaBreast Cancer Swiss Cancer Institute 29
Large-scale testing (Phase 3)Ended earlyNCT04592861What this trial is testingCarbon Ion RT for Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Albert Einstein College of Medicine 5
Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Not applicableLooking for participantsNCT06905145What this trial is testingMolecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker AnalysisWho this might be right forHead and Neck Squamous Cell CarcinomaLocally Advanced Stage National Cancer Institute, Naples 128
Testing effectiveness (Phase 2)Study completedNCT00022139What this trial is testingRadiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)Study completedNCT01635270What this trial is testingPhase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung CarcinomaWho this might be right forNon-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more Centre Leon Berard 54
Testing effectiveness (Phase 2)Ended earlyNCT03815942What this trial is testingVAccination in Early and ADvanced Prostate caNCErWho this might be right forIntermediate Risk Prostate CancerCastration-resistant Prostate Cancer University of Oxford 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT06381154What this trial is testingPhotoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerWho this might be right forLocally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more Mayo Clinic 24
Testing effectiveness (Phase 2)Looking for participantsNCT06471205What this trial is testingBL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast CancerWho this might be right forTriple-negative Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT00282022What this trial is testingVNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung CancerWho this might be right forLung Cancer Vion Pharmaceuticals 87
Testing effectiveness (Phase 2)UnknownNCT02504229What this trial is testingDC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentWho this might be right forGastric Cancer Beijing Biohealthcare Biotechnology Co.,Ltd 80
Not applicableEnded earlyNCT01872377What this trial is testingDose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic CancerWho this might be right forPancreatic Carcinoma Non-resectable Ottawa Hospital Research Institute 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03547973What this trial is testingStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadWho this might be right forMetastatic Urothelial Cancer Gilead Sciences 502